AB Science S.A. (AB)
Euronext
Real-time Data
07:00 AM
Day's Range
0.671552 wk Range
0.5010Overview - AB - AB Science S.A.
Key Statistics
Valuation
Enterprise Value
63.31M
P/E (Trailing)
‪-23.76‬
P/E (Forward)
‪-5.25‬
PEG Ratio
‪-5.25‬
Price / Sales (TTM)
‪60.43‬
EV / EBITDA
‪84.98‬
Profitability
Profit Margin
‪-132.62%‬
Operating Margin
‪510.92%‬
Return on Assets
‪1.67%‬
Return on Equity
‪9.05%‬
Ownership
Shares Outstanding
66.36M
Float
18.11M
Held by Insiders
‪47.70%‬
Held by Institutions
‪0.0030%‬
Price stats
Beta
‪1.16‬
50-Day Avg
‪0.7236‬
200-Day Avg
‪1.08‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - AB - AB Science S.A.
Peers - AB - AB Science S.A.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on Euronext.
Profile Summary - AB - AB Science S.A.
About
AB Science S.A. is a clinical-stage pharmaceutical company headquartered in Paris, France, founded in 2001. It specializes in the research, design, development, and marketing of innovative drugs targeting diseases with high unmet medical needs, particularly in oncology, inflammatory diseases, and neurological…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
